In this statement for the record, ACH urged Congress to preserve the 340B Program’s essential role in supporting community health center services while advancing targeted reforms that strengthen transparency, accountability and patient access. ACH’s recommendations include protecting contract pharmacy arrangements, prohibiting insurer and PBM discrimination, requiring upfront manufacturer discounts and granting HRSA clear regulatory authority.